BC Innovations | May 9, 2018
Distillery Therapeutics

Cancer

INDICATION: Colorectal cancer; breast cancer Cell culture and mouse studies identified an imidazoquinolinone-based ATM inhibitor that could help treat colorectal cancer or triple-negative breast cancer (TNBC) in combination with Camptosar irinotecan or Lynparza olaparib, respectively....
Items per page:
1 - 1 of 1